HK Stock MarketDetailed Quotes

TIMELESS (08028)

Watchlist
  • 0.220
  • -0.010-4.35%
Market Closed Apr 30 16:00 CST
111.31MMarket Cap-9.57P/E (TTM)

TIMELESS (08028) Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2025
(FY)Mar 31, 2025
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
Cash flow from operating activities
Earning before tax
----
23.99%-16.04M
----
-118.02%-21.1M
----
-121.47%-9.68M
----
-35.83%45.07M
----
162.55%70.24M
Profit adjustment
Interest (income) - adjustment
----
53.56%-1.12M
----
41.99%-2.4M
----
-9.82%-4.14M
----
-281.09%-3.77M
----
-62.66%-989K
Dividend (income)- adjustment
----
----
----
----
----
----
----
0.00%-750K
----
0.00%-750K
Attributable subsidiary (profit) loss
----
-81.12%88K
----
417.78%466K
----
129.61%90K
----
-400.99%-304K
----
-99.08%101K
Impairment and provisions:
----
-99.76%20K
----
1,485.90%8.44M
----
-73.24%532K
----
--1.99M
----
----
-Impairmen of inventory (reversal)
----
----
----
--18K
----
----
----
--1.43M
----
----
-Impairment of trade receivables (reversal)
----
-99.76%20K
----
--8.42M
----
----
----
----
----
----
-Other impairments and provisions
----
----
----
----
----
-4.49%532K
----
--557K
----
----
Revaluation surplus:
----
-23.57%2.66M
----
174.80%3.48M
----
-73.91%1.27M
----
335.55%4.85M
----
147.32%1.11M
-Fair value of investment properties (increase)
----
350.00%2.34M
----
140.00%520K
----
-285.71%-1.3M
----
-68.75%700K
----
507.27%2.24M
-Other fair value changes
----
-89.22%319K
----
15.32%2.96M
----
-38.20%2.57M
----
468.74%4.15M
----
37.58%-1.13M
Asset sale loss (gain):
----
-188.24%-245K
----
---85K
----
----
----
-3,088.58%-7.59M
----
1,370.00%254K
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
----
----
-1,686.73%-7.27M
----
---407K
-Loss (gain) on sale of property, machinery and equipment
----
-11.76%-95K
----
---85K
----
----
----
-148.26%-319K
----
3,405.00%661K
-Loss (gain) from selling other assets
----
---150K
----
----
----
----
----
----
----
----
Depreciation and amortization:
----
-5.45%347K
----
9.23%367K
----
-83.28%336K
----
-92.69%2.01M
----
0.75%27.5M
-Depreciation
----
-5.45%347K
----
9.23%367K
----
-83.28%336K
----
-92.69%2.01M
----
0.75%27.5M
Financial expense
----
-14.29%186K
----
-8.05%217K
----
-64.08%236K
----
-3.24%657K
----
-1.88%679K
Special items
----
-41.67%231K
----
--396K
----
----
----
----
----
----
Operating profit before the change of operating capital
----
-35.66%-13.86M
----
10.00%-10.22M
----
-126.93%-11.36M
----
-57.04%42.17M
----
215.05%98.15M
Change of operating capital
Inventory (increase) decrease
----
-328.17%-4.89M
----
-38,200.00%-1.14M
----
-99.97%3K
----
18,133.33%8.66M
----
-100.61%-48K
Accounts receivable (increase)decrease
----
---3.21M
----
----
----
-99.87%5K
----
205.81%3.71M
----
---3.51M
Accounts payable increase (decrease)
----
777.66%8.01M
----
-625.15%-1.18M
----
96.86%-163K
----
-222.66%-5.19M
----
1,093.66%4.23M
prepayments (increase)decrease
----
163.70%3.47M
----
-184.36%-5.45M
----
-62.98%6.46M
----
1,185.26%17.44M
----
524.06%1.36M
Special items for working capital changes
----
63.91%-1.08M
----
---3M
----
----
----
----
----
---1.5M
Cash  from business operations
----
44.87%-11.57M
----
-315.41%-21M
----
-107.57%-5.05M
----
-32.32%66.78M
----
158.12%98.68M
Other taxs
----
---621K
---622K
----
----
94.48%-999K
97.98%-333K
-35.05%-18.11M
-446.77%-16.49M
-49.29%-13.41M
Special items of business
-1,599.44%-12.24M
----
81.45%-720K
----
32.49%-3.88M
----
-107.20%-5.75M
----
1,666.96%79.9M
----
Net cash from operations
-811.77%-12.24M
41.91%-12.2M
65.43%-1.34M
-246.85%-21M
36.18%-3.88M
-112.44%-6.05M
-109.59%-6.08M
-42.91%48.68M
4,108.16%63.42M
191.53%85.27M
Cash flow from investment activities
Interest received - investment
-40.23%468K
-44.42%1.1M
-30.65%783K
-45.17%1.98M
-45.25%1.13M
7.18%3.61M
64.57%2.06M
240.85%3.37M
451.98%1.25M
62.66%989K
Dividend received - investment
----
----
----
----
----
----
----
0.00%750K
----
0.00%750K
Decrease in deposits (increase)
-132.67%-10.92M
--0
--33.42M
---32.66M
----
----
----
----
----
----
Sale of fixed assets
----
11.76%95K
----
--85K
--85K
----
----
--319K
----
----
Purchase of fixed assets
-12,480.00%-629K
94.59%-4K
---5K
85.96%-74K
----
-1,021.28%-527K
----
---47K
----
----
Purchase of intangible assets
----
---780K
----
----
----
----
----
----
----
---11.66M
Sale of subsidiaries
----
----
----
----
----
----
----
----
----
--407K
Acquisition of subsidiaries
----
----
----
-30.00%-195K
---195K
---150K
----
----
----
----
Recovery of cash from investments
-70.00%45K
-98.62%150K
-98.60%150K
600.51%10.89M
590.23%10.73M
-82.35%1.55M
--1.56M
--8.81M
----
----
Cash on investment
78.16%-311K
-414.29%-2.92M
-315.16%-1.42M
95.43%-567K
---343K
10.02%-12.4M
----
---13.78M
----
----
Other items in the investment business
----
----
----
----
----
----
----
----
--124K
----
Net cash from investment operations
-134.46%-11.34M
88.54%-2.35M
188.55%32.92M
-159.73%-20.54M
215.43%11.41M
-1,261.27%-7.91M
162.67%3.62M
93.89%-581K
117.19%1.38M
-4,497.10%-9.52M
Net cash before financing
-174.67%-23.58M
64.97%-14.55M
319.54%31.58M
-197.50%-41.54M
405.23%7.53M
-129.03%-13.96M
-103.81%-2.47M
-36.51%48.1M
2,926.34%64.79M
160.84%75.75M
Cash flow from financing activities
New borrowing
--30M
-200.00%-9.8M
----
8.89%9.8M
----
45.16%9M
----
--6.2M
----
----
Refund
----
----
27.78%-6.5M
19.64%-9M
-80.00%-9M
-12.00%-11.2M
---5M
---10M
----
----
Issuing shares
----
216.93%30.7M
----
--9.69M
----
----
----
----
----
----
Interest paid - financing
----
15.45%-186K
----
5.58%-220K
----
64.54%-233K
----
3.24%-657K
----
1.88%-679K
Dividends paid - financing
----
-196.79%-16M
-196.79%-16M
53.21%-5.39M
---5.39M
69.25%-11.52M
----
-187.37%-37.47M
---27.7M
27.73%-13.04M
Absorb investment income
----
--792K
----
----
----
----
----
----
----
----
Issuance expenses and redemption of securities expenses
----
32.11%-258K
----
---380K
----
----
----
----
----
----
Other items of the financing business
87.02%-17K
----
-194.93%-131K
----
187.90%138K
----
53.55%-157K
----
0.00%-338K
----
Net cash from financing operations
232.50%29.98M
16.83%5.26M
-58.77%-22.63M
132.24%4.5M
-176.36%-14.25M
66.72%-13.95M
81.61%-5.16M
-201.90%-41.92M
-8,196.15%-28.04M
30.74%-13.89M
Effect of rate
-76.88%120K
98.93%-38K
112.47%519K
56.84%-3.57M
68.29%-4.16M
-271.49%-8.27M
-738.95%-13.12M
-23.43%4.82M
26.24%2.05M
336.74%6.3M
Net Cash
-28.47%6.4M
74.91%-9.29M
233.10%8.95M
-32.69%-37.04M
11.78%-6.73M
-552.20%-27.91M
-120.74%-7.62M
-90.02%6.17M
1,938.44%36.75M
588.00%61.87M
Begining period cash
-18.56%40.95M
-44.68%50.28M
-44.68%50.28M
-28.47%90.89M
-28.47%90.89M
9.47%127.07M
9.47%127.07M
142.26%116.07M
142.26%116.07M
15.23%47.91M
Cash at the end
-20.55%47.47M
-18.56%40.95M
-25.31%59.75M
-44.68%50.28M
-24.76%80M
-28.47%90.89M
-31.35%106.32M
9.47%127.07M
201.66%154.88M
142.26%116.07M
Cash balance analysis
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Zhongzheng Tianheng Certified Public Accountants Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Sep 30, 2025(FY)Mar 31, 2025(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021
Cash flow from operating activities
Earning before tax ----23.99%-16.04M-----118.02%-21.1M-----121.47%-9.68M-----35.83%45.07M----162.55%70.24M
Profit adjustment
Interest (income) - adjustment ----53.56%-1.12M----41.99%-2.4M-----9.82%-4.14M-----281.09%-3.77M-----62.66%-989K
Dividend (income)- adjustment ----------------------------0.00%-750K----0.00%-750K
Attributable subsidiary (profit) loss -----81.12%88K----417.78%466K----129.61%90K-----400.99%-304K-----99.08%101K
Impairment and provisions: -----99.76%20K----1,485.90%8.44M-----73.24%532K------1.99M--------
-Impairmen of inventory (reversal) --------------18K--------------1.43M--------
-Impairment of trade receivables (reversal) -----99.76%20K------8.42M------------------------
-Other impairments and provisions ---------------------4.49%532K------557K--------
Revaluation surplus: -----23.57%2.66M----174.80%3.48M-----73.91%1.27M----335.55%4.85M----147.32%1.11M
-Fair value of investment properties (increase) ----350.00%2.34M----140.00%520K-----285.71%-1.3M-----68.75%700K----507.27%2.24M
-Other fair value changes -----89.22%319K----15.32%2.96M-----38.20%2.57M----468.74%4.15M----37.58%-1.13M
Asset sale loss (gain): -----188.24%-245K-------85K-------------3,088.58%-7.59M----1,370.00%254K
-Loss (gain) from sale of subsidiary company -----------------------------1,686.73%-7.27M-------407K
-Loss (gain) on sale of property, machinery and equipment -----11.76%-95K-------85K-------------148.26%-319K----3,405.00%661K
-Loss (gain) from selling other assets -------150K--------------------------------
Depreciation and amortization: -----5.45%347K----9.23%367K-----83.28%336K-----92.69%2.01M----0.75%27.5M
-Depreciation -----5.45%347K----9.23%367K-----83.28%336K-----92.69%2.01M----0.75%27.5M
Financial expense -----14.29%186K-----8.05%217K-----64.08%236K-----3.24%657K-----1.88%679K
Special items -----41.67%231K------396K------------------------
Operating profit before the change of operating capital -----35.66%-13.86M----10.00%-10.22M-----126.93%-11.36M-----57.04%42.17M----215.05%98.15M
Change of operating capital
Inventory (increase) decrease -----328.17%-4.89M-----38,200.00%-1.14M-----99.97%3K----18,133.33%8.66M-----100.61%-48K
Accounts receivable (increase)decrease -------3.21M-------------99.87%5K----205.81%3.71M-------3.51M
Accounts payable increase (decrease) ----777.66%8.01M-----625.15%-1.18M----96.86%-163K-----222.66%-5.19M----1,093.66%4.23M
prepayments (increase)decrease ----163.70%3.47M-----184.36%-5.45M-----62.98%6.46M----1,185.26%17.44M----524.06%1.36M
Special items for working capital changes ----63.91%-1.08M-------3M-----------------------1.5M
Cash  from business operations ----44.87%-11.57M-----315.41%-21M-----107.57%-5.05M-----32.32%66.78M----158.12%98.68M
Other taxs -------621K---622K--------94.48%-999K97.98%-333K-35.05%-18.11M-446.77%-16.49M-49.29%-13.41M
Special items of business -1,599.44%-12.24M----81.45%-720K----32.49%-3.88M-----107.20%-5.75M----1,666.96%79.9M----
Net cash from operations -811.77%-12.24M41.91%-12.2M65.43%-1.34M-246.85%-21M36.18%-3.88M-112.44%-6.05M-109.59%-6.08M-42.91%48.68M4,108.16%63.42M191.53%85.27M
Cash flow from investment activities
Interest received - investment -40.23%468K-44.42%1.1M-30.65%783K-45.17%1.98M-45.25%1.13M7.18%3.61M64.57%2.06M240.85%3.37M451.98%1.25M62.66%989K
Dividend received - investment ----------------------------0.00%750K----0.00%750K
Decrease in deposits (increase) -132.67%-10.92M--0--33.42M---32.66M------------------------
Sale of fixed assets ----11.76%95K------85K--85K----------319K--------
Purchase of fixed assets -12,480.00%-629K94.59%-4K---5K85.96%-74K-----1,021.28%-527K-------47K--------
Purchase of intangible assets -------780K-------------------------------11.66M
Sale of subsidiaries --------------------------------------407K
Acquisition of subsidiaries -------------30.00%-195K---195K---150K----------------
Recovery of cash from investments -70.00%45K-98.62%150K-98.60%150K600.51%10.89M590.23%10.73M-82.35%1.55M--1.56M--8.81M--------
Cash on investment 78.16%-311K-414.29%-2.92M-315.16%-1.42M95.43%-567K---343K10.02%-12.4M-------13.78M--------
Other items in the investment business ----------------------------------124K----
Net cash from investment operations -134.46%-11.34M88.54%-2.35M188.55%32.92M-159.73%-20.54M215.43%11.41M-1,261.27%-7.91M162.67%3.62M93.89%-581K117.19%1.38M-4,497.10%-9.52M
Net cash before financing -174.67%-23.58M64.97%-14.55M319.54%31.58M-197.50%-41.54M405.23%7.53M-129.03%-13.96M-103.81%-2.47M-36.51%48.1M2,926.34%64.79M160.84%75.75M
Cash flow from financing activities
New borrowing --30M-200.00%-9.8M----8.89%9.8M----45.16%9M------6.2M--------
Refund --------27.78%-6.5M19.64%-9M-80.00%-9M-12.00%-11.2M---5M---10M--------
Issuing shares ----216.93%30.7M------9.69M------------------------
Interest paid - financing ----15.45%-186K----5.58%-220K----64.54%-233K----3.24%-657K----1.88%-679K
Dividends paid - financing -----196.79%-16M-196.79%-16M53.21%-5.39M---5.39M69.25%-11.52M-----187.37%-37.47M---27.7M27.73%-13.04M
Absorb investment income ------792K--------------------------------
Issuance expenses and redemption of securities expenses ----32.11%-258K-------380K------------------------
Other items of the financing business 87.02%-17K-----194.93%-131K----187.90%138K----53.55%-157K----0.00%-338K----
Net cash from financing operations 232.50%29.98M16.83%5.26M-58.77%-22.63M132.24%4.5M-176.36%-14.25M66.72%-13.95M81.61%-5.16M-201.90%-41.92M-8,196.15%-28.04M30.74%-13.89M
Effect of rate -76.88%120K98.93%-38K112.47%519K56.84%-3.57M68.29%-4.16M-271.49%-8.27M-738.95%-13.12M-23.43%4.82M26.24%2.05M336.74%6.3M
Net Cash -28.47%6.4M74.91%-9.29M233.10%8.95M-32.69%-37.04M11.78%-6.73M-552.20%-27.91M-120.74%-7.62M-90.02%6.17M1,938.44%36.75M588.00%61.87M
Begining period cash -18.56%40.95M-44.68%50.28M-44.68%50.28M-28.47%90.89M-28.47%90.89M9.47%127.07M9.47%127.07M142.26%116.07M142.26%116.07M15.23%47.91M
Cash at the end -20.55%47.47M-18.56%40.95M-25.31%59.75M-44.68%50.28M-24.76%80M-28.47%90.89M-31.35%106.32M9.47%127.07M201.66%154.88M142.26%116.07M
Cash balance analysis
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Zhongzheng Tianheng Certified Public Accountants Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More